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Hsp90 middle domain phosphorylation initiates
a complex conformational program to recruit
the ATPase-stimulating cochaperone Aha1
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Complex conformational dynamics are essential for function of the dimeric molecular cha-
perone heat shock protein 90 (Hsp90), including transient, ATP-biased N-domain dimer-
ization that is necessary to attain ATPase competence. The intrinsic, but weak, ATP
hydrolyzing activity of human Hsp90 is markedly enhanced by the co-chaperone Aha1.
However, the cellular concentration of Aha1 is substoichiometric relative to Hsp90. Here we
report that initial recruitment of this cochaperone to Hsp90 is markedly enhanced by
phosphorylation of a highly conserved tyrosine (Y313 in Hsp90α) in the Hsp90 middle
domain. Importantly, phosphomimetic mutation of Y313 promotes formation of a transient
complex in which both N- and C-domains of Aha1 bind to distinct surfaces of the middle
domains of opposing Hsp90 protomers prior to ATP-directed N-domain dimerization. Thus,
Y313 represents a phosphorylation-sensitive conformational switch, engaged early after client
loading, that affects both local and long-range conformational dynamics to facilitate initial
recruitment of Aha1 to Hsp90.
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The molecular chaperone heat shock protein 90 (Hsp90) isessential for cellular proteostasis in eukaryotes. It facilitatesthe maturation, stability, and activity of >200 Hsp90-
dependent proteins, termed clients. The chaperone performs
these functions by collaborating with an array of cellular proteins
referred to as cochaperones1.
Hsp90 is composed of an ATP-binding N-terminal domain
(Hsp90-N) that attains ATPase competence upon structural
rearrangement of the protein, a middle domain (Hsp90-M)
involved in client interaction, and a C-terminal domain (Hsp90-
C) mediating homodimerization. Hsp90-N and Hsp90-M are
joined by an unstructured region of variable length consisting of
mainly charged amino acids and referred to as the charged lin-
ker2. All three Hsp90 domains interact with various cochaper-
ones. Aha1 can interact simultaneously with both Hsp90-M and
Hsp90-N3–6.
Aha1 is the primary activator of Hsp90 ATPase activity7, and is
comprised of an N-terminal domain (Aha1-N) and a C-terminal
domain (Aha1-C) which are connected by a ﬂexible linker. Aha1-
N interacts with Hsp90-M in a nucleotide-independent manner,
while the interaction between Aha1-C and Hsp90-N is sig-
niﬁcantly enhanced by ATP binding to Hsp90-N, as is the
interaction between full length Aha1 and Hsp903,4. Binding of
Aha1 facilitates conformational changes in Hsp90 necessary to
establish transient N-domain dimerization, including rearrange-
ment and re-orientation of the catalytic loop in Hsp90-M,
repositioning of Hsp90 N-domain and M-domain, and facilita-
tion of ATP lid closure in Hsp90-N, leading to marked stimula-
tion of Hsp90 ATPase activity6,8.
Hsp90 is constitutively dimerized via the C-terminal domain of
each protomer. In the nucleotide-free state Hsp90 adopts a V-
shaped conformation in which the N-domains of each protomer
are not associated. ATP binding biases the chaperone toward
transient closure of the N-domains, resulting in a conformation
that is competent for ATP hydrolysis. Post-hydrolysis, Hsp90
returns to an open conformation. It has been suggested that the
dwell time in each state is crucial for Hsp90 to optimally process
its client proteins3,9. As the major Hsp90 ATPase accelerator in
the cell, Aha1 thus plays a key role in regulating the timing of the
Hsp90 chaperone cycle.
Post-translational modiﬁcations (PTMs), including phosphor-
ylation, acetylation, S-nitrosylation, oxidation, ubiquitination,
and sumoylation, are increasingly appreciated as regulating dis-
tinct aspects of Hsp90 function in eukaryotic cells, particularly
in metazoans2,10–13. Together with the appearance of cochaper-
ones, an increasing variety and abundance of PTMs allows for
precise tuning of the Hsp90 chaperone cycle in response to both
diverse environmental cues and the needs of speciﬁc clients.
Further, molecular modeling studies suggest that some Hsp90
PTMs serve as conformational switches that facilitate allosteric
regulation of chaperone structure during the chaperone cycle14.
Adding to the complexity of Hsp90 regulation in higher
eukaryotes, PTMs affecting particular cochaperones may syner-
gize with PTMs of Hsp90. Thus, tyrosine phosphorylation of
Cdc37, a cochaperone that interacts with Hsp90 client kinases,
results in partial unfolding of its C-terminal domain, which in
turn facilitates Hsp90 phosphorylation in the Hsp90 N-domain
that regulates interaction with Cdc3715. Such synergistic interplay
between Cdc37 and Hsp90 provides directionality to the Hsp90
cycle16.
We previously reported that Hsp90/Aha1 interaction is dra-
matically enhanced by phosphorylation of the highly conserved
Y313 residue in Hsp90-M (amino acid numbering based on
human Hsp90α)16. In that study, we used isothermal titration
calorimetry (ITC) to show that phosphomimetic substitution
(Y313E) increases Hsp90 afﬁnity for Aha1 by ~3.5-fold.
Consistent with this observation, Hsp90 complexed with Aha1
in vivo is greater than seven times more likely to be phos-
phorylated on Y313 compared to the general pool of the cha-
perone, suggesting a correlative relationship between Y313
phosphorylation and Aha1 binding in cells16. The current study
was undertaken to explore the mechanistic basis underlying these
observations.
Using several orthogonal techniques, we show that Hsp90-
Y313 is a phosphorylation-sensitive conformational switch in the
M-domain that acts early in the chaperone’s conformational cycle
(after client loading) to stimulate Aha1 recruitment. Unexpect-
edly, this is accomplished by markedly enhancing Aha1-C afﬁnity
for Hsp90-M while the chaperone is still in an open conforma-
tion. This requires that Aha1-N and Aha1-C domains simulta-
neously bind to distinct surfaces on the M-domain of each Hsp90
protomer. As might be predicted from this model, Y313 mod-
iﬁcation is asymmetric and need not occur simultaneously on
both Hsp90 protomers.
Results
Hsp90-Y313 phosphorylation promotes Aha1 C-domain
binding. We showed previously that Hsp90 bound to Aha1 in
cells was phosphorylated on Y313 to signiﬁcantly higher levels
than was the general intracellular pool of Hsp90 immunopreci-
pitated with the antibody AC8816. Since AC88 favors free Hsp90
that is not in complex with client proteins17, in the current study
we tested Hsp90 precipitated using another antibody, H90-10,
which recognizes Hsp90 in complex with clients18. We found
that, like the Hsp90 immunoprecipitated with AC88, the Hsp90
fraction isolated by H90-10 immunoprecipitation was phos-
phorylated on Y313 to a substantially lesser degree than that seen
for Hsp90 coprecipitated with Aha1 (Fig. 1a), conﬁrming that
Hsp90 in complex with Aha1 is preferentially phosphorylated on
Y313 compared to the general cellular pool of the chaperone.
Consistent with this observation, phosphomimetic substitution of
Y313 with glutamic acid (Y313E) dramatically increased Hsp90
association with Aha1 (Fig. 1b).
Interestingly, while increasing Aha1 association, Y313E
phosphomimetic substitution decreased Hsp90 association with
another cochaperone, p60Hop (Fig. 1b). This ﬁnding was
conﬁrmed by reciprocal immunoprecipitation, in which FLAG-
p60Hop and HA-Hsp90α were co-transfected into HEK293 cells.
After FLAG immunoprecipitation followed by blotting for HA,
we observed markedly less coprecipitating HA-Hsp90-Y313E
compared to wild-type HA-Hsp90 (Fig. 1c). P60Hop participates
in the early, client loading step of the Hsp90 chaperone cycle
(when Hsp90 N-domains are undimerized) and it competes
with Aha1 for binding to Hsp902. These data suggest that
Y313E phosphomimetic substitution speciﬁcally affects an early
transition step between dissociation of p60Hop and recruitment
of Aha1 to Hsp90.
In contrast to its impact on p60Hop association with Hsp90,
binding of the cochaperone p23 is minimally affected by Y313
phosphomimetic mutation (Fig. 1b). P23 binds most strongly to
the N-domains of a fully closed (e.g., N-domain dimerized)
Hsp90 dimer and thus stabilizes a late stage in the Hsp90
chaperone cycle at which point Hsp90 is capable of ATP
hydrolysis19,20. However, ATP-dependent interaction of p23
with the middle domain of both yeast and human Hsp90 prior
to N-domain dimerization has also been reported, although the
functional consequences of this secondary interaction remain
obscure21–23. Since it is technically difﬁcult to visualize the
population of human Hsp90 occupying the closed state (without
cross-linking) even in the presence of ATP24, we considered the
presence or absence of p23 in these Hsp90 immunoprecipitates
to be uninformative for this study.
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Human Aha1 comprises an N-terminal domain (Aha1-N,
amino acid 1–162) and a C-terminal domain (Aha1-C, amino
acid 201–338) connected by a linker of about 30 amino acids3.
Each Aha1 domain folds well by itself and can independently
interact with Hsp903,4,6. To investigate which Aha1 domain is
responsible for the increased interaction with Y313-
phosphorylated Hsp90, we compared Aha1-N and Aha1-C
association with wild-type and Y313-mutated Hsp90. Similar to
results with full-length Aha1, a higher level of Hsp90 was detected
in Aha1-C immunoprecipitates with the phosphomimetic Hsp90-
Y313E compared to wild-type Hsp90 (Fig. 1d). However, this was
not observed in Aha1-N immunoprecipitates. These results
indicate that the enhanced interaction between Hsp90-Y313E
and full length Aha1 is mediated by the C-terminal domain of
Aha1. Importantly, these data are fully consistent with the Kd
values of full-length Aha1, Aha1-N, and Aha1-C for both wild-
type Hsp90 and Hsp90-Y313E (Supplementary Table 3). It is
worth noting that a phenylalanine substitution of Y313 (Y313F)
resulted in a mild increase in Hsp90 interaction with both full-
length Aha1 and Aha1-C (Fig. 1d). This is likely due to a local
change in Hsp90 conformation caused by disruption of a
hydrogen bond between Y313 and D319 in Hsp90-M (see the
section “Discussion”).
The Aha1-C β-sheet mediates enhanced binding to Hsp90-
Y313E. To further investigate the nature of Y313E-stimulated
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Fig. 1 Y313 phosphorylation-promoted Hsp90–Aha1 interaction is mediated by Aha1-C. a Hsp90-associated Aha1 is phosphorylated on Y313 to a higher
level compared to the general Hsp90 pool. Hsp90 was immunoprecipitated from transfected 293A cells with speciﬁc antibodies (H90-10 or AC88) or co-
precipitated with FLAG-tagged Aha1. Hsp90 protein levels were examined by western blot, and Y313 phosphorylation was detected with an antibody
speciﬁc for the phosphorylation of this site. b Y313 phosphomimetic substitution increases Hsp90 interaction with Aha1 but decreases the interaction with
p60Hop. FLAG-tagged Hsp90 was immunoprecipitated from transfected cells. Co-precipitated endogenous Aha1, p23, and p60Hop were detected by
western blot. Precipitated Hsp90 proteins were stained with Coomassie Blue (CBB). c Y313E substitution decreases Hsp90 association with p60Hop. FLAG-
p60Hop was co-expressed with HA-Hsp90 and was immunoprecipitated from cells. Hsp90 and p60Hop were detected by western blot with indicated
antibodies. d Y313E phosphomimetic substitution in Hsp90 increases association of wild-type Aha1 and Aha1-C but not Aha1-N. FLAG-tagged Aha1 (wild-
type or individual domains) were co-expressed with HA-tagged Hsp90, and complexes were immunoprecipitated with anti-FLAG resin. Exogenous Hsp90
was detected by western blot with anti-HA antibody. E= glutamic acid, F= phenylalanine. Bottom: schematic illustration of the Aha1 protein. e Point
mutations in Aha1-C substantially decrease association with Hsp90-Y313E. Experiments were performed as in d. Endogenous co-precipitated Hsp90 (wild-
type) was discerned with the antibody SPS-771, which signiﬁcantly favors recognition of untagged Hsp90. Bottom: Schematic illustration of Aha1 with
point-mutations indicated. f K273A mutation in Aha1-C abolishes the stimulatory effect of Y313 phosphomimetic substitution on Aha1 association.
Experiments were performed as in d. Please see Supplementary Fig. 1 for more information. Source data for this ﬁgure are provided as a Source Data File
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Hsp90–Aha1 interaction, we examined the structure of Aha1-C.
NMR experiments have shown that the human Aha1-C domain
in solution contains a β-sheet of ﬁve strands packed against a
bundle of three α-helixes4 (Supplementary Fig. 1, PDB 1 X53
[https://doi.org/10.2210/pdb1X53/pdb]). Interestingly, the β-4
strand could be crosslinked to both Hsp90-N and Hsp90-M
domains, and the lysine residue K273 in β-3 was protected by
Hsp90 from reacting with chemically active reagents3, indicating
that the β-sheet of Aha1-C interacts with Hsp90. To examine the
potential involvement of this β-sheet in Hsp90 interaction pro-
moted by Y313 phosphomimetic mutation, we made point
mutations in the Aha1-C β-sheet and compared the association of
these (full-length) mutants with Hsp90-Y313E to that of wild-
type Aha1. At comparable expression levels, Aha1-C β-sheet
mutants K273A, K208A/K212A and E260A/D263A displayed
markedly less interaction with Hsp90-Y313E than did wild-type
Aha1 (Fig. 1e, top panel), conﬁrming that the Aha1-C β-sheet
plays a key role in the enhanced interaction of full-length Aha1
with Hsp90-Y313E. Endogenous Hsp90 interaction was slightly
reduced by these Aha1-C β-sheet mutations (compare top two
panels in Fig. 1e), possibly reﬂecting the small amount of Y313
phosphorylation occurring on endogenous Hsp90.
Hsp90–Aha1 interaction is enhanced by ATP and its non-
hydrolyzable analog AMPPNP. Molybdate, a phosphate analog,
stabilizes an ATP-like Hsp90 conformation by occupying the
binding site of the γ-phosphate after ATP hydrolysis25,26. To
query the ATP dependence of Y313E-stimulated Hsp90–Aha1
interaction in cells, we compared Hsp90–Aha1 association
between wild-type Aha1 and Aha1-K273A, in the presence and
absence of molybdate. Molybdate markedly increased Hsp90
interaction with wild-type Aha1 (Fig. 1f, lanes 1 and 3), as
expected. In contrast, even in the absence of molybdate Hsp90
Y313E mutation dramatically increased wild-type Aha1 interac-
tion compared to wild-type Hsp90 (Fig. 1f, lanes 1 and 2).
Interestingly, addition of molybdate caused a further increase in
Aha1 association with Hsp90-Y313E, suggesting an additive effect
with ATP (Fig. 1f, lanes 2 and 4). In the case of Aha1-K273A, on
the other hand, Y313E mutation of Hsp90 failed to impact
association of the two proteins, either in the presence or absence
of molybdate (Fig. 1f, lanes 5, 6 and 7, 8). Together, these data
suggest that the phosphomimetic Y313E mutation promotes
Hsp90–Aha1 association by a mechanism that may act
cooperatively with ATP, consistent with the possibility that
phosphorylation of this residue may facilitate Aha1 recruitment
during an early transition step between open and closed Hsp90
conformations.
Aha1/Hsp90-Y313E binding does not require N-domain clo-
sure. The preceding data demonstrate that Y313E-induced
Hsp90–Aha1 interaction is mediated by Aha1-C. Since Aha1-C
is proposed to preferentially interact with the N-domain interface
of an Hsp90 dimer in a closed (e.g., N-domain dimerized) con-
formation, we asked whether Y313 phosphomimetic mutation
requires a closed conformation of Hsp90 to enhance Aha1
interaction. To evaluate this possibility, we made use of two
Hsp90 point mutations (R400A, H210A) that interfere with N/M
domain rearrangements required for N-domain dimerization (see
Fig. 2a and Supplementary Table 1). The amino acid R380 in the
M-domain of yeast Hsp90 contacts N-domain-bound ATP and
facilitates closure of Hsp90 N-domains27. Likewise, mutation of
the equivalent residue, R400, in human Hsp90 hinders formation
of a stable, ATP-dependent rearrangement of Hsp90 N/M-
domains that is required for ATP hydrolysis27. We found that
R400A mutation abolished Aha1 interaction with wild-type
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Fig. 2 Aha1 interaction with Hsp90-Y313E is independent of Hsp90 N-domain closure. a Schematic illustration of Hsp90 monomer and dimer, showing the
boundaries of the domains and the location of the mutations used in this ﬁgure. b Dimerization-inhibiting mutation in Hsp90 fails to counteract the
stimulatory effect of Y313E on Aha1 interaction. FLAG-tagged Hsp90, wild-type, or indicated mutants were expressed in 293A cells, immunoprecipitated
with the M2 anti-FLAG antibody and veriﬁed with CBB staining after electrophoresis. Co-precipitated Aha1 was examined by western blot. c The H210A
mutation in Hsp90-N differentially affects Aha1 interaction with wild-type and Y313E Hsp90. Immunoprecipitation and western blot for indicated proteins
were performed as in b. d The H210A mutation in Hsp90 completely abolishes the effect of the closed conformation-inducing Hsp90 mutation E47A on
Aha1 association. Experiments were carried out as described in b. e Y313E and E47A in Hsp90 additively promote Aha1 interaction. The triple mutant
E47A/H210A/Y313E displays partially restored Aha1 interaction. Experiments were performed as above. Please see Supplementary Fig. 2a, b for more
information. Source data for this ﬁgure are provided as a Source Data File
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Hsp90 (Fig. 2b, compare lanes 1 and 2). Signiﬁcantly, inclusion of
Y313E in an R400A Hsp90 mutant rescued Aha1 association
(Fig. 2b, compare lanes 2–4). Together, these data suggest that
Y313 phosphomimetic mutation promotes Aha1 interaction with
N-domain undimerized Hsp90.
Speciﬁc binding between yeast Hsp90 N-domains and Aha1
C-domain has been observed in the presence of AMPPNP4.
Using NMR, nucleotide-dependent changes in chemical shift in
the presence of either Aha1-C or full-length Aha1 were detected
at several locations within the Hsp90 N-domain, including helix
1, the ATP lid region, and at amino acid H197 (H210 in
Hsp90α)4. H210 is located at the interface between the N-
domain and M-domain of Hsp90, packing between E28, R32,
R196, and F349 (Supplementary Fig. 2b), suggesting involve-
ment of this amino acid in ATP-dependent N/M-domain
rearrangement necessary for ATP hydrolysis. To test this
possibility, we compared both the Aha1-binding afﬁnity and
the ATPase activity of wild-type Hsp90 and Hsp90-H210A. The
Kd of Aha1 binding to Hsp90-H210A is increased by two-fold
compared to wild-type Hsp90, while the Kd of AMPPNP
binding is minimally affected by this mutation (Supplementary
Table 2). As predicted, we found that H210A mutation reduced
Hsp90-speciﬁc basal ATPase activity by >90% and, in contrast
to wild-type Hsp90, this activity was not inducible by Aha1
(Supplementary Fig. 2a). These ﬁndings are consistent with the
likelihood that Hsp90 N-domain and M-domain are unable to
properly re-orient in the presence of H210A. Immunoprecipita-
tion of FLAG-Hsp90 from HEK293 cells showed that H210A
mutation abrogated Aha1 association with Hsp90. However, as
was the case for mutation of R400, addition of an H210A
mutation only modestly decreased Aha1 association with
Hsp90-Y313E (Fig. 2c). Thus, two mutations that independently
interfere with ATP-dependent N/M-domain rearrangement
necessary for N-domain dimerization have minimal impact on
enhanced Aha1 interaction with Hsp90 caused by phosphomi-
metic mutation of Y313, consistent with the hypothesis that
Y313E facilitates an early step in Aha1 recruitment to N-domain
undimerized Hsp90.
Hsp90 E47A (see Fig. 2a) is a mutation of the catalytic glutamic
acid. Thus, this mutation does not interfere with ATP binding but
does compromise ATP hydrolysis and stabilizes the N-domain
dimerized, closed conformation of Hsp9028. Introduction of
E47A dramatically increases Aha1 interaction with Hsp90
(Fig. 2d, compare lanes 2 and 3). Inclusion of H210A markedly
reduced Aha1 interaction with Hsp90-E47A (Fig. 2d), in contrast
to its minimal impact on Aha1 binding to Hsp90-Y313E (Fig. 2c,
lanes 3 and 4). Similar to the additive effect of molybdate and
Hsp90 Y313E mutation (Fig. 1f), Y313E and E47A mutations
synergistically increase Aha1 association with Hsp90 (Fig. 2e,
lanes 1–3). Importantly, inclusion of Y313E partially rescues
Aha1 interaction with Hsp90-E47A/H210A (Fig. 2e, compare
lanes 4 and 5). Together, these data suggest that Y313
phosphomimetic mutation induces an Hsp90 conformation that
uniquely favors Aha1 interaction prior to N-domain dimeriza-
tion, and this is mediated by enhanced binding of Aha1-C to
Hsp90. This hypothesis is fully consistent with the Kd values,
determined in the presence and absence of AMPPNP, of full-
length Aha1, Aha1-N, and Aha1-C for both wild-type Hsp90 and
Hsp90-Y313E (Supplementary Table 3). Intriguingly, these data
show that the Kd of Aha1-C for Hsp90-Y313E is reduced by more
than two-fold in the presence of AMPPNP, while the Kd of Aha1-
C for binding to Hsp90-Y313E compared to wild-type Hsp90
(both in the presence of AMPPNP) is reduced by nearly seven-
fold (Supplementary Table 3), consistent with an additive or
cooperative role for ATP binding and Y313 phosphomimetic
mutation (vide infra).
Local and long-range conformational impact of Y313 muta-
tion. Taken together, these ﬁndings suggest Y313E mutation
enhances Aha1 association by affecting Hsp90 conformation
without promoting N-domain dimerization. To explore this
possibility further, we employed hydrogen exchange-mass spec-
trometry (HDX) and NMR spectroscopy. The rate of exchange of
amide protons yields information on solvent accessibility and
hydrogen bonding of various parts of a protein in solution,
enabling one to differentiate solvent exposed regions (higher
exchange rate) from buried or highly structured regions (lower
exchange rate)29, while signal broadening and chemical shifts of
NMR spectra provide information on altered protein dynamic
and structural properties. Collection and analysis of HDX data
were performed in the absence of nucleotides. The most sig-
niﬁcant changes in hydrogen exchange and thus in conforma-
tional dynamics (altered solvent accessibility of Hsp90-Y313E
compared to wild-type Hsp90) were observed in the region sur-
rounding Y313 in the Hsp90-Y313E M-domain. Speciﬁcally,
hydrogen exchange for Hsp90-Y313E in this region was drama-
tically increased, compared to wild-type Hsp90, particularly in
peptides comprising aa286–308 (Fig. 3), which constitutes the
extension from the C-terminal end of the charged linker and the
turn leading to helix-11 in Hsp90-M, where Y313 resides (PDB
2CG9[https://doi.org/10.2210/pdb2CG9/pdb], Supplementary
Fig. 3a). Greater exchange was also observed for the peptide
aa313–324, which includes the C-terminal half of helix-11 and
the turn after it. In wild-type Hsp90, this loop–helix–loop module
packs against a β-sheet comprised of ﬁve β-strands extending
from amino acids 324 to 391 in Hsp90-M. It is very likely that this
region becomes markedly more mobile in Hsp90-Y313E (perhaps
contributing to the decreased migration of the protein, compared
to wild-type Hsp90, in SDS gels). Indeed, the data suggest a
moderate increase in solvent exposure of this β-sheet region, as
evidenced by increased hydrogen exchange in peptides from
aa344–351, 384–398, and 384–401.
NMR signal line widths were used to assess the impact of Y313
modiﬁcation on the dynamics of Hsp90 that occur on a faster
timescale than is measurable with HDX. Comparison of the 13C
HMQC spectrum of isoleucine (Ile)-labeled Hsp90 to the
spectrum of Hsp90-Y313E in the absence of nucleotide reveals
that for a large number of Hsp90-M Ile residues that are not
limited to the vicinity of Y313 (I296, I304, I361, I370, I378, I385,
I398, I445, and I491), signals experience changes in chemical shift
and severe line broadening (Fig. 4 and Supplementary Fig. 4a, b).
Signal broadening is not a result of Hsp90-Y313 aggregation, as is
evident by the comparison of its elution proﬁle through an
analytical gel-ﬁltration column or the linewidths of signals from
all three domains, with respect to wild-type Hsp90 (Supplemen-
tary Fig. 4c). Therefore, this phosphomimetic substitution has a
profound impact on the structural and dynamic properties of
Hsp90-M, causing a dramatic enhancement in millisecond
timescale sampling of multiple conformations.
This altered Hsp90-M state affects the conformational proper-
ties of N-domain and C-domain, as well as N-/M-interdomain
and M-/C-interdomain association, suggesting that Y313 phos-
phorylation elicits a global effect on the properties of Hsp90. In
particular, the signals of I43, I214, and I398 which lie at the
Hsp90-N/M interface show signiﬁcant chemical shift changes
(Fig. 4 and Supplementary Fig. 4a, b), indicating that Y313
phosphorylation induces a unique Hsp90-N/-M orientation
relative to wild-type Hsp90. However, this reorientation of the
Hsp90-N/M interface is not accompanied by inter-protomer
dimerization of the N-domains in a manner that resembles the
ATP-promoted closed conformation. Thus, the signals of I26, I33,
and I110, which lie at the interface of dimerized N-domains and
serve as excellent probes of the closed state, do not exhibit any
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change in chemical shift in Hsp90-Y313E relative to wild-type
Hsp90 (Fig. 4 and Supplementary Fig. 4b).
In agreement with this observation, increased hydrogen
exchange was detected in the region containing aa20–70, which
comprises the C-terminal half of β-strand 1, helixes 1 and 2, and
the turn in between the two helices (Fig. 3 and Supplementary
Fig. 3a). Since β-strand 1 and helix 1 are less solvent-exposed in
the closed (N-dimerized) conformation of the Hsp90 dimer
(Supplementary Fig. 3a), increased hydrogen exchange in this
region supports the hypothesis that Y313E phosphomimetic
mutation hinders association of the two protomers. Increased
exchange in helix 2, which is partially buried in the Hsp90 closed
conformation, is consistent with this interpretation (Fig. 3 and
Supplementary Fig. 3a). AMPPNP-induced association of Hsp90-
Y313E N-domains further support this hypothesis. The NMR
data show that, in the presence of AMPPNP, Hsp90-Y313E
acquires a similar closed conformation as the one observed for
wild-type Hsp90, as evidenced by the positions of I26, I33, I110
and other Hsp90-N signals (Supplementary Fig. 4d, e).
Compared to wild-type Hsp90, Hsp90-Y313E displayed
decreased hydrogen exchange in the absence of nucleotide in
the region of the ATP lid (peptide comprised of aa99–119, Fig. 3).
Interestingly, decreased hydrogen exchange has been observed in
the same region of human Hsp90β in the presence of both ATP
and ADP19, suggesting the possibility of overlapping impact of
nucleotide binding and Y313 phosphorylation on mobility of the
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Fig. 3 Y313 phosphomimetic substitution affects conformation of all Hsp90 domains. Hydrogen exchange mass spectrometry shows global impact of
Y313E phosphomimetic substitution on Hsp90 conformation. Puriﬁed human Hsp90α (wild-type or Hsp90-Y313E) was diluted 1:20 into D2O buffer and
incubated for 30 s at 30 °C in the absence of nucleotide. The reaction was quenched with ice cold quench buffer, the protein digested with immobilized
pepsin, desalted and analyzed by liquid chromatography mass spectrometry (LC–MS). Deuteron incorporation into Hsp90-Y313E minus deuteron
incorporation into wild-type Hsp90 is plotted for all peptic peptides (shown is the difference between each pair of means ± standard error for n= 3
independent experiments). For each peptide, bars depicting increased exchange for Hsp90-Y313E (compared to wild-type Hsp90) extend to the right,
while bars showing decreased exchange for Hsp90-Y313E relative to wild-type Hsp90 extend to the left. Red lines indicate domain boundaries. CL, charged
linker. The source data ﬁle contains the mean values ± SEM of deuteron incorporation for each corresponding peptide obtained from wild-type Hsp90 and
Hsp90-Y313E, as well as the difference between the two sets of means ± SEM. The values underlying the means are no longer available
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Hsp90 ATP lid. Further, we observed chemical shift changes for
Ile residues on the opposite side of the lid, speciﬁcally I59, I78,
I91, and I96 (Fig. 4 and Supplementary Fig. 4a), suggesting that
structural changes are propagated throughout the nucleotide-
binding domain.
The notion of long-range conformational effects propagated by
Y313 phosphomimetic substitution is also strengthened by altered
hydrogen exchange observed in the Hsp90 C-terminal domain.
Increased exchange in Hsp90-Y313E was detected for peptide
aa611–645. However, a slight decrease was observed for the
shorter peptide aa611–628 (Fig. 3), suggesting that the increase
observed in the longer peptide fragment likely is due to
aa629–645, a region that is buried in the fully closed conforma-
tion of wild-type Hsp90 (Supplementary Fig. 3a). Increased
exchange was also observed in the C-terminal region (aa711–728)
leading to the TPR domain-binding segment MEEVD (Fig. 3),
consistent with the likelihood that the C-terminal tail of Hsp90-
Y313E is more solvent exposed as a consequence of Y313
phosphorylation. Intriguingly, ATP binding to Hsp90-N results
in similar deprotection of Hsp90β in this region19.
Y313E mutation increases Hsp90-M/Aha1-C interaction.
Aha1-C has been reported to interact with both N-domain and
M-domain of Hsp903,4. It has been proposed that interaction
between Aha1-C and Hsp90-M is transient and Aha1-C switches
to interact with Hsp90-N upon ATP binding and dimerization of
the N-domains of each protomer3. Since phosphomimetic sub-
stitution of Y313 promotes Aha1 association via Aha1-C and does
not appear to elicit or require the closed conformation of Hsp90,
we hypothesized that this mutation may serve to facilitate Aha1-C
interaction with Hsp90-M. To test this hypothesis, we monitored
changes in the 13C HMQC spectrum of Ile-labeled Hsp90-Y313E
in the presence of perdeuterated full-length Aha1, Aha1-N, or
Aha1-C, and we compared the data obtained to the corre-
sponding titrations of wild-type Hsp90. Indeed, addition of Aha1-
C to Hsp90-Y313E causes prominent chemical shift changes to a
large set of Ile signals from Hsp90-M (I361, I370, I378, I385, I445,
I491, I494, I519), as well as several undeﬁned Ile signals from
Hsp90-C. Addition of Aha1-C to Hsp90-Y313E also causes small
shift or broadening to I49 and I131 from Hsp90-N (Figs. 5, 6 and
Supplementary Fig. 5). On the other hand, binding of Aha1-C has
only a limited impact on signals obtained from wild-type Hsp90,
including those of I361 and I445 from Hsp90-M, I43, I49, and
I110 from Hsp90-N, as well as the same set of Hsp90-C signals
that are perturbed when Hsp90-Y313E was titrated (Figs. 5, 6 and
Supplementary Fig. 5).
Based on the forgoing data, we conclude that Aha1-C interacts
in distinct ways with wild-type Hsp90 and the phosphomimetic
mutant. Although Aha1-C binds in a dynamic fashion to
multiple Hsp90 domains, the altered Hsp90-M conformation
and relative domain orientation presented by Y313E-Hsp90
allows Aha1-C to interact preferentially with Hsp90-M. Titration
with Aha1-N, however, does not reveal such a differential
effect. As expected on the basis of the available structure of
Hsp90-M in complex with Aha1-N, perturbations occur only
for Ile signals of Hsp90-M and the N/M interface (I49, I214,
I304, I361, I370, I378, I385, I398, I445, I449, and I494) (Figs. 5, 6
and Supplementary Fig. 5). With the exception of I304 and
I361, which lie in the vicinity of the mutation, all other
signals shift in the same direction for both wild-type and
Hsp90-Y313E, suggesting that in contrast to Aha1-C, the mode
of Aha1-N interaction with Hsp90 is not sensitive to, or slightly
inhibited by, the presence of the phosphomimetic mutation.
This interpretation of the data is fully consistent with the co-
immunoprecipitation of individual Aha1 domains with wild-
type Hsp90 and Hsp90-Y313E, as well as with the Kd values
for full-length Aha1, Aha1-N and Aha1-C binding to either wild-
type Hsp90 or Hsp90-Y313E, as described above.
When the titration of full-length Aha1 to Hsp90 is considered,
the effect on the spectra of both wild-type and Hsp90-Y313E
recapitulates a combined effect obtained from titration of the
isolated domains, which is in agreement with the previously
proposed globular nature of Aha1, where Aha1-N and Aha1-C
domains are joined through a long, ﬂexible linker. In this respect,
signals that are uniquely affected by the addition of either Aha1-
N or Aha1-C (e.g. I449 by Aha1-N and C6 by Aha1-C; C6
refers to an Ile residue in Hsp90-C for which no assignment is
currently available) display similar changes in the presence of
full-length Aha1 (Figs. 5, 6 and Supplementary Fig. 5). Despite
the apparent overlap observed for the Aha1-N and Aha1-C
binding sites on Hsp90-M, steric considerations suggest that
initial binding of the two Aha1 domains more likely occurs via
interaction with opposite faces of the M domains of the two
Hsp90 protomers.
To further explore the interaction between Aha1 and Hsp90,
we examined lysine cross-linking between wild-type Hsp90, or
Hsp90-Y313E, and Aha1, in the presence or absence of
AMPPNP, using mass spectrometry. In total we identiﬁed 147
non-redundant cross-linked peptide pairs and selected 22 for
targeted quantitative mass spectrometry using a parallel reaction
monitoring (PRM) method (Supplementary Data 1). Five non-
redundant cross-linked peptide pairs were quantiﬁed between
Aha1 and Hsp90 (wild-type and Y313E) and reﬂected differences
between wild-type Hsp90 and Hsp90-Y313E in response to
I59,I96
I78,I91
I43,I214,
I370,I398
I296,I304
I445
I494
I96
I43
I370
I378
I26
I110
I361,I378,I385
Fig. 4 Y313E-induced conformational changes probed by methyl-TROSY
NMR. Selected regions from the overlay of the 1H-13C-HMQC spectra of
wild-type (black) and Hsp90-Y313E (red), showing signals that experience
changes in chemical shifts and signiﬁcant line broadening. The bottom
panel includes an overlay of wild-type Hsp90 in the AMPPNP bound state
(green) for I26 and I110 that undergo large chemical shift changes upon
nucleotide addition due to Hsp90-N/N dimerization (see Supplementary
Fig. 4). The Ile residues that experience signiﬁcant chemical shift changes
after phosphomimetic mutation mapped on the structure of Hsp90 in the
closed state. One subunit is shown in gray, while in the other subunit N-,
M- and C-domain of Hsp90 are colored blue, green, and orange,
respectively. The site of the phosphomimetic mutation is shown in pink.
Source data for this ﬁgure are provided as a Source Data File
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AMPPNP (Fig. 7 and Supplementary Fig. 3b; note that the data in
Supplementary Fig. 3b represent a ratio of values for either wild-
type Hsp90 or Hsp90-Y313E obtained in the presence and
absence of AMPPNP, while the individual integrated peak areas
are shown in Fig. 7). Incubating Hsp90 with AMPPNP prior to
Aha1 addition tended to decrease the relative levels of the Hsp90-
Aha1 cross-links, agreeing with prior cross-linking observations
for Aha1 and Hsp90β3. Generally, the AMPPNP-induced changes
were greater for wild-type Hsp90 than for Hsp90-Y313E
(Supplementary Fig. 3b). We found two cross-links between the
C-terminal half of Aha1 and Hsp90-M (K189Aha1-K362Hsp90 and
K208Aha1-K443Hsp90) for both Hsp90-Y313E and wild-type
Hsp90 (Fig. 7 and Supplementary Fig. 3b). The K208Aha1-
K443Hsp90 cross-link displayed a reduction in relative level after
pretreatment of Hsp90 with AMPPNP, but this reduction was
similar for both wild-type Hsp90 and Hsp90-Y313E (Supple-
mentary Fig. 3b). In contrast, although AMPPNP reduced
the relative level of cross-links between K189Aha1–K362Hsp90
Y313E-Hsp90 +
Aha1 Aha1
361
304
445
110
449 49
C6
43
i
ii
iii
iv
v
Aha1-C Aha1-CAha1-N Aha1-N
Wild-type Hsp90 +
Fig. 5 Modulation of Aha1–Hsp90 interaction by Y313E phosphomimetic substitution. Selected sets of signals from the titration of Y313E (left, black) or
wild-type Hsp90 (right, black) with wild-type Aha1 (green), Aha1-N (cyan), or Aha1-C (pink). The lower panel shows the signal of an Ile residue from
Hsp90-C for which no assignment is currently available (designated C6). Roman numbering denotes boxes extracted from the complete spectra shown in
Supplementary Fig. 5
I398
I214,I370
I304,I361
I378,I385
I445,I449
I494
I49,I131
I370
I361
I378,I385
I445
I491, I494, I519
Fig. 6 Aha1-N and Aha1-C chemical shift perturbations mapped on the Hsp90 closed dimer. Aha1-N affected Hsp90 residues are shown in cyan and Aha1-
C affected residues are shown in pink. The closed Hsp90 dimer is shown in dark and light gray, and the position of the Y313 phosphomimetic mutation is
shown in yellow. The position of Aha1-N is modeled in complex with one of the two protomers. All Hsp90-C Ile residues are depicted in gray
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(wild-type Hsp90), the relative level of cross-links between
K189Aha1 and K362Hsp90-Y313E in the absence of AMPPNP was
very similar to that of wild-type Hsp90 in the presence of
AMPPNP, and it changed little upon addition of this nucleotide
to Hsp90-Y313E (Fig. 7). This can also be visualized by
comparing the cross-link ratio data for this cross-link pair
(Supplementary Fig. 3b). These data support the possibility that
Hsp90-Y313E is poised for a more rapid transition (compared to
wild-type Hsp90) from the open to the ATP-potentiated N-
domain dimerized state.
The other three inter-protein cross-links that we found were
between Aha1-C and Hsp90-N (K203Aha1-K112Hsp90, K208Aha1-
K112Hsp90, and K203Aha1-K209Hsp90). Each of these three cross-
links displayed a similar trend of reduced levels with AMPPNP,
although at a larger magnitude for wild-type Hsp90 than for
Hsp90-Y313E (Fig. 7 and Supplementary Fig. 3b). We also
examined Hsp90 intra-protomer cross-links, comparing wild-
type Hsp90 to Hsp90-Y313E, in the presence and absence of
AMPPNP (Supplementary Fig. 3b, c). One intra-protomer cross-
link between K58Hsp90-K112Hsp90, which spans the Hsp90 ATP-
binding pocket, displayed a much larger change in the presence of
AMPPNP for wild-type Hsp90 than for Hsp90-Y313E. Two
additional intra-protomer cross-links, K362Hsp90-K292Hsp90 and
K414Hsp90-K410Hsp90, showed substantial variations between
wild-type Hsp90 and Hsp90-Y313E, as did several inter-
protomer cross-links, K414homodimer, K443homodimer, and
K631homodimer (Supplementary Fig. 3b, c). Together, these results
support a conformational impact of Y313 phosphomimetic
mutation throughout all Hsp90 domains, some of which mimic
those induced by AMPPNP.
Hsp90-Y313E stimulation of Aha1 binding is asymmetric.
Hsp90 functions as a homodimer in cells. Thus, we investigated
whether Y313 phosphorylation on both protomers is required to
promote maximal Aha1 interaction. We co-expressed wild-type
Hsp90 and Hsp90-Y313E with either FLAG or HA tag, and we
performed sequential immunoprecipitations to isolate Hsp90
dimers with one protomer tagged with FLAG and the other
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this ﬁgure are provided as a Source Data File
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tagged with HA (Fig. 8a). We found that the heterodimer wild-
type Hsp90/Hsp90-Y313E and the homodimer Hsp90-Y313E/
Hsp90-Y313E yielded a comparable amount of co-precipitated
Aha1 (Fig. 8a, lower panel, lanes 2, 3). The increased Aha1 in lane
3 compared to lane 2 in the ﬁrst-round immunoprecipitation is
likely due to the additional presence of an Hsp90 dimer with both
protomers tagged with HA, resulting in homodimers of Hsp90-
Y313E/Hsp90-Y313E in lane 3 and homodimers of wild-type
Hsp90/wild-type Hsp90 in lane 2 (Fig. 8a, upper panel). These
data indicate that Y313 phosphorylation on only one protomer of
the Hsp90 dimer is sufﬁcient to promote enhanced Aha1 asso-
ciation (see also Fig. 8c, lanes 1 and 2).
To further deﬁne the interaction between Hsp90-M and Aha1-
C that is enhanced by Y313 phosphorylation, we introduced a
W320A point mutation in Hsp90 (see Supplementary Table 1).
W320 is structurally close to Y313, and mutation of its
homologous site in yeast Hsp90, W300, was reported to affect
Aha1 association30. We ﬁrst examined how W320A affected
Hsp90 interaction with the individual domains of Aha1, and we
found that it signiﬁcantly reduced association of Aha1-C while
minimally affecting Aha1-N interaction, suggesting that its
impact is mechanistically distinct from that of V411E Hsp90
mutation, which disrupts Hsp90-M interaction with Aha1-N6
(Fig. 8b).
Next, we investigated the effect of introducing W320A either in
cis or trans to Hsp90-Y313E. Sequential immunoprecipitations
showed that W320A did not affect Aha1 association when it was
in the protomer opposite to the one harboring Y313E (Fig. 8c,
lane 5), but it completely disrupted Aha1 interaction when it was
in the same protomer with Y313E (Fig. 8c, lane 6), conﬁrming
that W320 mutation functions in cis to disrupt Hsp90–Y313E
interaction with Aha1-C. Taken together, these data support a
model in which Y313 phosphorylation enhances interaction
between Hsp90-M of the phosphorylated protomer with the
C-domain of Aha1, while the Aha1 N-domain interacts with
Hsp90-M of the opposite protomer (Fig. 9, step c).
Our preceding data suggest a model in which phosphomimetic
substitution of Hsp90-Y313 initiates Aha1 association at an early
step of the conformational cycle that is initiated upon Hsp90
binding a client protein. To determine whether N-domain ATP
binding, in contrast to ATP-mediated N-domain dimerization,
is necessary for stable association of Aha1 with either wild-type
Hsp90 or Hsp90-Y313E, we ﬁrst examined Hsp90-D93A (see
Supplementary Table 1) association with the isolated N-domain
and C-domain of Aha1. Hsp90α D93A mutation disrupts
nucleotide binding to Hsp90-N31. We observed a moderate
decrease in Aha1-N interaction with this Hsp90 mutant, suggesting
either a subtle, long-range impact of the mutation itself on Hsp90-
M conformation or an ATP-dependent effect on Aha1-N binding
to Hsp90-M. At the same time, we observed a complete loss of
interaction of Aha1-C, consistent with the prevailing model that
some level of ATP-binding is required for stable Aha1-C
interaction with Hsp90-N (Fig. 8b). We then examined the
importance of ATP for Aha1 interaction with Hsp90-Y313E.
Surprisingly, sequential immunoprecipitation showed that Hsp90-
D93A mutation fully disrupted the enhanced Aha1 interaction
promoted by Y313E phosphomimetic substitution, whether D93A
was in the same or the opposite protomer as Y313E (Fig. 8c, lanes 3
and 4). These results indicate that nucleotide binding to both
Hsp90 N-domains is necessary for stable interaction of Aha1 with
Hsp90-Y313E, even if the direct effect of Y313 phosphomimetic
mutation is to enhance formation of a transient Aha1/Hsp90
complex in which both domains of Aha1 interact independently
with Hsp90-M. These data are consistent with a recent study
demonstrating the cooperativity of nucleotide binding to both
Hsp90 N-domains and its regulation by Aha132.
Fig. 8 Enhanced Hsp90–Y313E–Aha1 interaction depends on Aha1-C binding
to Hsp90-M domain. a Phosphomimetic substitution of Y313 in one
protomer of Hsp90 is sufﬁcient to stimulate Aha1 association. HA or FLAG
tagged Hsp90, wild-type or Y313E, were co-expressed in 293A cells and
sequentially immunoprecipitated with anti-HA and anti-FLAG antibody-
linked resins. The ﬁrst round of IP was performed with anti-HA antibody-
linked resin; bound proteins were eluted with HA peptide and then loaded
onto anti-FLAG antibody-linked resin. Proteins puriﬁed from the second
round of IP were eluted with SDS-sample buffer and subjected to western
blot analysis. Indicated proteins were detected with speciﬁc antibodies.
b Hsp90 interaction with Aha1-N is abrogated by mutation in Hsp90-M
while interaction with Aha1-C is compromised by mutation in both Hsp90-N
and Hsp90-M. FLAG-tagged Aha1-N or Aha1-C was co-expressed with HA-
tagged Hsp90, wild-type or with the indicated mutations. Aha1 domains
were immunoprecipitated with mouse anti-FLAG antibody-linked resin, and
Hsp90 was detected by western blot with rat anti-HA antibody. c FLAG or
HA tagged Hsp90, wild-type or mutants, were co-expressed in 293A cells
and sequentially immunoprecipitated and analyzed as in panel a. Y313E-
stimulated association of full-length Aha1 with Hsp90 requires
phosphomimetic mutation of Y313 on only one protomer, but requires ATP
binding to Hsp90-N on both protomers, since D93A mutation on either
protomer negates the impact of Y313E. Aha1 binding to Hsp90-Y313E is also
disrupted by W320A mutation in cis (on the same protomer containing
Y313E), but no disruption occurs when W320 mutation occurs in trans to
Y313E. Source data for this ﬁgure are provided as a Source Data File
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Fig. 9 Y313 phosphorylation recruits Aha1 to Hsp90. The model shown here
focuses on early steps in the cycle as Hsp90 proceeds from a client-loaded
open conformation to dissociation of the client-loading co-chaperone
p60HOP, and ﬁnally to recruitment of the ATPase-stimulating co-chaperone
Aha1. An apo-Hsp90 dimer adopts the open conformation with the two N-
domains un-engaged (a). Apo-Hsp90 can bind the co-chaperone p60HOP
to facilitate client transfer from Hsp70 (not shown in the cartoon) to
Hsp90. Phosphorylation of Y313 in the Hsp90 middle domain induces a
conformational change (b), weakening interaction with HOP and promoting
recruitment of Aha1. Aha1 binds to the Hsp90 dimer while Hsp90 N-
domains remain disassociated, with Aha1-N interacting with Hsp90-M of
the un-phosphorylated Hsp90 protomer and Aha1-C interacting with
Hsp90-M of the Hsp90 protomer bearing phosphorylated Y313 (c).
Sumoylation of K191 in Hsp90-N in the presence of ATP33 promotes a
repositioning of Aha1-C to engage the N-dimerized closed conformation
that is required for activation of Hsp90 ATPase activity (d). Hydrolysis of
ATP to ADP, and subsequent release of ADP, bias Hsp90 to re-occupy the
open conformation, enabling it to re-enter the ATP-directed
chaperone cycle
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Discussion
Hsp90 exists as a homodimer and its chaperone activity requires
traversal of a conformational cycle whose directionality is pri-
marily dependent on ATP binding and hydrolysis. Binding of
ATP biases Hsp90 towards closure of the two separated N-
terminal domains, and hydrolysis of ATP, which requires N-
domain dimerization, eventually leads to dissociation of the two
N-domains. The ATPase activity of human Hsp90 is very modest
and the most potent activator of this activity is the Hsp90 co-
chaperone Aha17. We previously reported that interaction
between Aha1 and Hsp90 in cells is enhanced by phosphorylation
on Y313 in the middle domain of Hsp9016. In this report, we
explored this observation in more detail and we describe its
mechanistic basis. We used the phosphomimetic glutamic acid
substitution of Y313 to facilitate our study. This substitution does
not compromise the overall structure of Hsp90 (see Supple-
mentary Fig. 4c) and largely recapitulates the effects of Y313
phosphorylation, both in vitro and in vivo16 (also see Fig. 1a, b
and Supplementary Table 3), while the equivalent mutation in
yeast (Hsp82-Y293E) supports viability (see Supplementary
Fig. 6). Further, Hsp90-Y313E retains basal ATPase activity and,
compared to wild-type Hsp90, is more responsive to stimulation
by Aha116.
In vitro, association of Hsp90 with Aha1 is increased by ATP
and AMPPNP; this has been interpreted as the result of enhanced
interaction between Aha1-C and dimerized Hsp90-N domains3,4.
Our results demonstrate that increased Hsp90–Aha1 interaction
caused by Y313E phosphomimetic substitution is mediated by
enhanced interaction of Aha1-C with Hsp90-M, but this inter-
mediate complex still requires that the N-domain of each Hsp90
protomer have the ability to bind ATP. In contrast, however, the
impact of this PTM on Aha1/Hsp90 interaction does not require
the N-domain dimerized, closed conformation of Hsp90. Rather,
it occurs at an early step after client loading, resulting in dis-
sociation of p60Hop and recruitment of Aha1, engendering a
unique conformation in which the N-domains of each Hsp90
protomer remain disassociated. This hypothesis is supported by
data derived from several orthogonal experiments. First, immu-
noprecipitation of Hsp90-Y313E yielded, in contrast to consistent
and markedly increased association of Aha1, a clear and sub-
stantial decrease in association of p60Hop, a co-chaperone that
associates with the N-domain undimerized conformation of
Hsp90 and whose binding to Hsp90-M competes with that of
Aha1. Second, while the nucleotide-stabilizing small molecule
molybdate has a clear effect on Aha1 binding to wild-type Hsp90,
it has a less dramatic, but additive impact on Aha1 binding to
Hsp90-Y313E. Third, mutations that interfere with ATP-induced
N–M domain repositioning (e.g., R400A and H210A), a pre-
requisite for N-domain dimerization, do not block Aha1
recruitment to Hsp90-Y313E. Fourth, E47A, an Hsp90 mutant
that retains ATP binding but lacks ATPase activity, thus biasing
Hsp90 towards an ATP-dependent closed conformation (with
stronger afﬁnity for Aha1), functions in an additive manner with
Y313E to promote Aha1 association. Fifth, hydrogen exchange
and NMR analyses show that the two N-domains of an Hsp90-
Y313E homodimer are not dimerized in the absence of AMPPNP,
but behave comparably to wild-type Hsp90 in the presence of this
nucleotide. Sixth, NMR data show that addition of Aha1-C to
Hsp90-Y313E results in prominent chemical shift changes within
Hsp90-M that are not seen upon Aha1-C addition to wild-type
Hsp90. Finally, NMR, ITC, and protein cross-linking data show
that, in some respects, Hsp90 Y313 phosphomimetic mutation
mimics the effect of AMPPNP on Hsp90 conformational
dynamics and afﬁnity for Aha1.
The extensive conformational impact of this phosphomimetic
mutation on Hsp90 is likely due to the unique location of Y313.
The conserved tyrosine localizes in Helix 11, packing against a β-
sheet in Hsp90-M. The hydroxyl moiety of Y313 is engaged with
the side chain of D319 via a hydrogen bond (PDB 3Q6M[https://
doi.org/10.2210/pdb3Q6M/pdb] and molecular modeling on PDB
2CG9[https://doi.org/10.2210/pdb2CG9/pdb] and PDB 5FWM
[https://doi.org/10.2210/pdb5FWM/pdb]). Phosphorylation of
Y313 would disrupt this interaction and is likely to signiﬁcantly
alter the conformational dynamics of Hsp90-M. Indeed, we
detected signiﬁcantly increased hydrogen exchange and broad-
ening of NMR linewidths in the region surrounding Y313 for
Hsp90-Y313E compared to wild-type Hsp90. Data from cross-
linking experiments are also consistent with this possibility. The
dynamic impact of Y313 phosphorylation is not limited to
Hsp90-M, since conformational changes are clearly transmitted
to both Hsp90 N-domain and C-domain as well. In addition,
chemical shift changes observed for Ile residues at the interface of
Hsp90 N-domain and M-domains indicate a unique reorientation
of the two domains upon Y313 phosphorylation.
We have incorporated our current ﬁndings into an existing
model16,33,34 of PTM-assisted Hsp90 cycling (Fig. 9). We identify
Y313 on Hsp90 as a phosphorylation-sensitive conformational
switch that initiates Aha1 recruitment to Hsp90, displacing
p60Hop after client loading and markedly enhancing Aha1-C
afﬁnity for Hsp90 while the chaperone is still in an open con-
formation. This initial interaction involves Aha1-N and Aha1-C
domains binding to opposing surfaces on the middle domain of
each Hsp90 protomer. Subsequently, ATP-dependent remodeling
of the Hsp90-N and Hsp90-M domains, stabilized by Aha1-C
binding to Hsp90-N, generates the closed conformation of the
chaperone poised for ATP hydrolysis.
Methods
Cells, plasmids, and antibodies. HEK293 (Catalog number ATCC CRL-1573)
cells were purchased from ATCC (Manassas, VA); 293A (Catalog number R70507)
cells were purchased from Invitrogen (Carlsbad, CA). Both cells were grown in
DMEM plus 10% fetal bovine serum. HA-tagged or FLAG-tagged Hsp90 sequence
was cloned into pcDNA3 using the Bam HI/Xho I cutting sites, with the tag at the
N-terminus of the Hsp90 sequence35. Plasmids expressing FLAG-tagged full length
or truncated Aha1 proteins were a kind gift from Dr. Paul LaPointe (University of
Alberta, Edmonton, Alberta, Canada)3. Point mutations were made by using the
QuikChange site-directed mutagenesis method following the protocol of the com-
pany (Agilent, Santa Clara, CA). Hsp90 mutations used in this study are delineated
in Supplementary Table 1. The forward primers used were as follows: Hsp90-E47A:
GAGATCTTTCTGAGAGCGCTCATTTCAAATTCATCAGATGC; Hsp90-D93A:
CTCTCACTATTGTGGCTACTGGAATTGGAATGAC; Hsp90-H210A: GGAGAT
TGTGAAGAAAGCTTCTCAGTTTATTGGATATCCC; Hsp90-Y313E:GGAGTA
CGGAGAATTCGAGAAGAGCTTGACCAATGAC; Hsp90-Y313F: GAGTACGG
AGAATTCTTTAAGAGCTTGACCAATGA; Hsp90-W320A: GAGCTTGACCAA
TGACGCGGAAGATCACTTGGC; Hsp90-V391: CAACAAAGCAAAATTTTGA
AAGAGATCAGGAAGAATTTGGTC. Each of these forward primers was paired
with its reverse complement for making the mutant using the QuikChange method.
Mouse anti-FLAG antibody (M2)-linked (Catalog number A2220) and anti-HA
antibody-linked (Catalog number A2095) resins, and rat monoclonal anti-HA
antibodies (Catalog number 12158167001) were from Sigma-Aldrich (St. Louis,
MO). Rabbit anti-Hsp90 (Catalog number 4877) and anti-Hop (Catalog number
5670) antibodies were purchased from Cell Signaling Technology (Beverly, MA).
Polyclonal rabbit anti-FLAG antibody (Catalog number TA150078) was from
ThermoFisher Scientiﬁc (Fremont, CA), and monoclonal mouse anti-FLAG
antibody was from Sigma-Aldrich (Catalog number F3165). Rat anti-Hsp90
(Catalog number SPA-835), rabbit anti-Hsp90α (Catalog number SPS-771), mouse
anti-Hsp90 (clone AC88), and anti-p23 polyclonal antibodies (Catalog number
ADI-SPA-670) were from Enzo Life Sciences (Farmingdale, NY). Rabbit anti-Aha1
antibody (Catalog number 600-401-974) was from Rockland Immunochemicals
(Limerick, PA). Site-speciﬁc rabbit anti-phosphoY313 polyclonal antibody was
developed in collaboration with Cell Signaling Technology (Beverly, MA)16. The
mouse anti-Hsp90 antibody H90-10 was a kind gift of Dr. Marc Cox (University of
Texas at El Paso). Throughout this study, unless otherwise noted, we have used
Hsp90 to designate human Hsp90α. Where relevant, measurements were taken
from distinct samples.
Immunoprecipitation and Western Blotting. Cultured HEK293 (ATCC, Mana-
ssas, VA) or 293A (Invitrogen, Carlsbad, CA) cells were transfected with Lipo-
fectamine 2000 following the manufacturer’s protocol (ThermoFisher Scientiﬁc,
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Fremont, CA). Twenty-four hours after transfection, cells were washed once with
PBS and lysed with Hepes buffer (20 mM Hepes, pH7.2, 100 mM NaCl, 1 mM
MgCl2, and 0.5% Nonidet P40) containing complete protease inhibitors and
phosSTOP phosphatase inhibitors (Sigma-Aldrich, St. Louis, MO). Lysis buffer was
supplemented with a ﬁnal concentration of 10 mM molybdate where indicated.
Protein concentration was determined using a BCA Protein Assay Kit (Thermo-
Fisher/Pierce Biotechnology, Rockford, IL). Immunoprecipitation was performed
by incubating anti-FLAG antibody-linked or anti-HA antibody-linked resins with
cleared cell lysate in microtubes. Resins were rotated at 4 °C for 1–2 h, washed three
times with Hepes buffer with or without 10 mM molybdate, 1 mL per tube. Bound
proteins were eluted with SDS-sample buffer (2% SDS, 10% glycerol, 0.1 M DTT,
0.002% bromophenol blue, and 0.08 M Tris–HCl pH6.8)36. For two-round
immunoprecipitation, bound proteins on the resins used for the ﬁrst round were
eluted by incubating with Hepes buffer containing 100 µg/mL FLAG or HA peptide
(Sigma-Aldrich) at 4 °C for 1 h. Eluate was loaded onto anti-HA or anti-FLAG
antibody-linked resins for the second round immunoprecipitation, and bound
proteins were eluted with SDS-sample buffer. Protein SDS–PAGE electrophoresis
was performed using the Criterion system from Bio-Rad (Bio-Rad Laboratories,
Hercules, CA), and the proteins in the gel were transferred to PVDF membrane
following the protocol of the company. For western blotting, the membrane was
ﬁrst blocked with 2% non-fat milk in TNE buffer (10 mM Tris, pH 7.5, 50 mM
NaCl, 2.5 mM EDTA, and 0.1% Tween 20). The primary antibodies were added
to the blocking buffer and incubated overnight at 4 °C. The membrane was then
washed three times with TNE buffer and incubated with horseradish peroxidase-
linked secondary antibody at room temperature for 1 h. The membrane was
washed again (four times) with TNE buffer, incubated with Pico ECL reagent from
ThermoFisher Scientiﬁc (Rockford, IL), and exposed to HyBlot CL auto-
radiography ﬁlm (Denville Scientiﬁc; Metuchen, NJ). Films were scanned with an
Epson Perfection V700 scanner (Epson, Long Beach, CA), and the images were
processed using Adobe Photoshop. All primary antibodies were used at a dilution
of 1:1000; secondary antibodies were diluted 1:5000. Uncropped and processed
blots and gels are provided in the Source Data ﬁle.
Amide hydrogen exchange. Wild-type Hsp90 or Hsp90-Y313E (5 µl 60 µM) were
pre-incubated in the absence of nucleotide for 5 min at 30 °C. Amide hydrogen
exchange was initiated by diluting the sample 20-fold into D2O containing 25 mM
Hepes/KOD pH 7.5, 10 mM KCl, and 5 mM MgCl2. After 30 s exchange at 30 °C,
reactions were quenched by mixing the sample 1:1 with ice-cold quench buffer
(400 mM KH2PO4/H3PO4 pH 2.2)37,38.
Quenched samples were injected directly into an HPLC-MS setup38 consisting
of a nanoAcquity UPLC (Waters Corp.), a Shimadzu 10AD-VP HPLC pump, a
Rheodyne 7725 manual injection valve with a 100 µl sample loop, a Microbore
guard column with 2 mm inner diameter (IDEX, #C-130B) ﬁlled with pepsin
(Sigma, #P6887) immobilized on Poros AL20 (Applied Biosystems, #1-6029-06), a
six-port valve with microelectric actuator (Valco, #EPC6W), a microbore guard
column with 1 mm inner diameter (IDEX, #C-128) ﬁlled with Poros R2 (Applied
Biosystems #1-1118-02) as trap column, and an Acquity UPLC BEH C8 analytical
column (Waters Corp. #186002876). Sample loop, trap column, and analytical
column were submerged in an ice/water bath. The sample was pumped through the
pepsin column onto the trap column at 200 µl min−1 (Shimadzu pump) and
desalted for 2.5 min using ice-cold 0.1% formic acid in water. The peptic peptides
were eluted from the trap column through the analytical column into the maXis
QTOF mass spectrometer (Bruker Daltonics GmbH, Vienna, Austria) using a 10-
min linear gradient of 90% ultrapure solvent A (0.1% formic acid in water)/10%
ultrapure solvent B (0.1% formic acid in acetonitrile) to 45% solvent A/55%
solvent B.
Data acquisition was performed on a maXis mass spectrometer (Bruker
Daltonics GmbH) and analysis was performed using the Data Analysis software
(Bruker Daltonics GmbH, Vienna, Austria)38. The identity of the peptides was
determined by several independent MS/MS runs of identical samples in the absence
of D2O, followed by MASCOT database searches. For the evaluation of deuteron
incorporation the m/z and intensity values of each isotopic peak were manually
extracted using the Data Analysis software and peptide centroid masses were
determined using a custom Excel (Microsoft) sheet. The calculated centroid values
were corrected for the back-exchange using a 100% deuterated sample prepared by
denaturing Hsp90α in 6M guanidinium/HCl and three cycles of lyophilizing the
sample and re-dissolving it in D2O.
Cross-linking of Hsp90 and Aha1. Puriﬁed protein concentrations were deter-
mined using the Bradford assay (Coomassie Protein Assay Kit, ThermoFisher/
Pierce Biotechnology, Rockford, IL). 100 µg (1.18 nmol) of wild-type Hsp90 or
Hsp90-Y313E dissolved in 50 µL of 25 mM HEPES pH 7.3, 100 mM NaCl were
incubated with AMPPNP at 10 mM ﬁnal concentration for 10 min on ice. Aha1-
His was added to wild-type Hsp90α or Hsp90α-Y313E at an equimolar ratio and
the mixture was incubated for 30 min on ice. Following incubation, the proteins
were cross-linked by the addition of BDP-NHP cross-linker39 at a ﬁnal con-
centration of 1 mM. The cross-linking reaction was allowed to proceed for 30 min
at room temperature. After 30 min 50 µL of 0.1 M Tris buffer at pH 8.0 was added,
followed by 100 µL of 8M urea in 0.1 M Tris pH 8.0. Disulﬁde bonds were reduced
with 5 mM TCEP for 30 min at room temperature, followed by alkylation with 10
mM iodoacetamide for 30 min at room temperature. The proteins were then
digested using a 1:100 ratio of trypsin and incubating at 37 °C for 16 h. Following
digestion, the resulting peptide mixture was desalted by solid phase extraction
using a 50 mg C18 Sep-Pak cartridge (Waters, Milford, MA) and corresponding
vacuum manifold to deliver solvents. The Sep-Pak cartridge was equilibrated by
passing through 1 mL of acetonitrile (ACN) containing 0.1% triﬂuoroacetic acid
(TFA), followed by 3 mL of H2O containing 0.1% TFA. The sample was acidiﬁed
by adding TFA to a ﬁnal concentration of 1% (v/v) and then passed through the
Sep-Pak cartridge at a ﬂow rate of 1 mL per minute. Excess salt was washed away
by passing 5 mL of H2O containing 0.1% TFA through the cartridge. Peptides were
eluted into a 2 mL Eppendorf tube by passing 1 mL of 80% ACN containing 0.1%
TFA through the cartridge. The sample was then concentrated by vacuum cen-
trifugation and adjusted to 100 µL ﬁnal volume with 0.1% formic acid before
LC–MS analysis.
LC–MS analysis. Identiﬁcation of cross-linked peptide pairs from the tryptic
digest samples of cross-linked Hsp90 (wild-type/Y313E) and Aha1 was accom-
plished using a liquid chromatography–mass spectrometry (LC–MS) system
comprised of a nano Acquity UPLC (Waters, Milford, MA) coupled to a Velos-
FTICR mass spectrometer (Thermo Fisher Scientiﬁc, Grand Island, NY). The
peptide samples were separated by reversed-phase chromatography using a 3
cm × 100 µm trapping column and a 60 cm × 75 µm analytical column both
packed with 5 µm Reprosil C8 particles with 120 Å pores (Dr. Maisch HPLC
GmbH, Ammerbuch, Germany). Peptides were loaded onto the trapping column
using a ﬂow rate 2 µL per minute to deliver an isocratic mobile phase compo-
sition of 98% solvent A (H2O containing 0.1% formic acid) and 2% solvent B
(acetonitrile containing 0.1% formic acid) for 10 min. Reversed phase separation
over the analytical column was performed by applying a linear gradient from
90% solvent A and 10% solvent B to 60% solvent A and 40% solvent B over 120
min at a ﬂow rate of 300 nL per minute. Eluting peptides were ionized by
electrospray ionization by applying a voltage of 2.2 kV to a laser-pulled tip at the
tip of the analytical column. The Velos-FTICR mass spectrometer was operated
using a real-time analysis for cross-linked peptide technology (ReACT) acqui-
sition method 30. A MS1 scan was performed in the ICR cell at a resolving power
of 50,000 using an automatic gain control (AGC) target value of 5E5 ions. The
most intense precursor ion with a charge state of ≥4 was isolated in the ion trap
with a 3m/z window, fragmented by collision-induced dissociation with a nor-
malized collision energy setting of 25 and the fragment ions measured by MS2
analysis in the ICR cell with a resolving power setting of 50,000 and an AGC
value of 2E5. The ReACT method performed a check for ions detected in the
MS2 scan that satisfy the expected mass relationship for cross-linked peptide
pairs (mass precursor ion=mass peptide 1+mass peptide 2+ reporter ion)
within a 20 ppm mass error tolerance. Released peptide ions that satisfy the
relationship were subjected to MS3 analysis in the ion trap analyzer using an
isolation window of 3m/z, a normalized collision energy of 35 and an AGC target
value of 5E4. Targeted quantitative analysis of 22 selected cross-linked peptide
pairs was accomplished by PRM. Reversed-phase chromatographic separation of
cross-linked peptide samples was performed using an EASY-nLC 1000 system
(Thermo Fisher Scientiﬁc, Grand Island, NY) equipped with a 3 cm × 100 µm
trapping column and a 60 cm × 75 µm analytical column both packed with 5 µm
Reprosil C8 particles with 120 Å pores (Dr. Maisch HPLC GmbH, Ammerbuch,
Germany). Peptides were loaded onto the trapping column using 20 µL of sol-
vent A (H2O containing 0.1% formic acid) at a ﬂow rate 2 µL per minute.
Reversed phase separation over the analytical column was performed by
applying a linear gradient from 98% solvent A and 2% solvent B (acetonitrile
containing 0.1% formic acid) to 60% solvent A and 40% solvent B over 120 min
at a ﬂow rate of 300 nL per minute. Eluting peptides were ionized by electrospray
ionization by applying a voltage of 2.2 kV to a laser pulled tip at the tip of the
analytical column. Mass spectrometry was performed using Q-Exactive Plus
mass spectrometer (Thermo Fisher Scientiﬁc, Grand Island, NY) operated using
a PRM method with the following settings: a resolving power of 17,500@200m/z,
AGC target of 2E5 ions, maximum ion time of 100 ms, isolation window of 3m/z
and a normalized collision energy of 27.
Data analysis. Assignment of cross-linked peptide sequences was performed by
using Comet v. 2018.01.240 to search the data generated from the ReACT LC–MS
experiments. Comet settings included: searching a database comprised of forward
and reverse Hsp90 (wild-type and Y313) and Aha1 protein sequences, a precursor
mass tolerance of 20 ppm allowing for −1, 0, 1, 2, or 3 13C offsets, allowing for only
fully tryptic peptide sequences with up to three missed cleavage sites, up to two
occurrences per peptide of oxidation of Met (15.9949 Da) as a variable modiﬁcation
and a single occurrence of the BDP cross-linker residual mass (197.032422 Da) on
Lys as a required modiﬁcation, carbamidomethylation of Cys (57.021464 Da) as a
ﬁxed modiﬁcation, fragment ion tolerance of 1.0005 Da with a bin offset of 0.4, and
a digest mass range from 600 to 5000 Da. The Comet search resulted in a total of
162 non-redundant fully assigned cross-linked peptide pairs, including 147 target
sequences and 15 decoys (peptide pair containing at least one reverse sequence
peptide) for a maximum estimated false discovery rate (FDR) of 10.2% at the non-
redundant peptide pair level (Supplementary Data 1). From this set of 147 target
peptide pairs, 22 conﬁdently (maximum estimated FDR 2.2%) assigned cross-
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linked peptide pairs, including ﬁve inter-protein links between Hsp90 and Aha1,
were selected for targeted quantitative PRM analysis.
Mass spectrometry data from the PRM experiments were analyzed using
Skyline (v. 3.5.0.9319)39. Transitions for cross-linked peptides were imported into
Skyline using the Cross-link Transition Calculator external tool (https://skyline.ms/
skyts/home/software/Skyline/tools/details.view?name=Cross-link%20Transition%
20Calculator). Integrated peak areas were exported from Skyline (Supplementary
Fig. 3b, c) and used to calculate the log2(AMPPNP/Apo) ratios for each cross-
linked peptide pair. Normalization across samples was accomplished by starting
with equivalent amount of protein, 1.18 nmol of Hsp90 (wild-type or Y313E) and
Aha1 as described in the cross-linking section of the methods above. Statistical
signiﬁcance was determined by calculation of the 95% conﬁdence intervals (n= 6
independent experiments) for the mean integrated peak areas, as well as the mean
log2(AMPPNP/Apo) values.
NMR spectroscopy. 1H-13C HMQC spectra (methyl-TROSY) of 2H/13C Ile-
labeled Hsp90 were acquired at 25 °C on an Agilent dd800 MHz instrument
equipped with a cryoprobe. Sample concentration for wild-type and Y313E Hsp90
ranged between 85 and 110 mM Hsp90, while the concentration of the 2H-labeled
partner (full-length Aha1, Aha1-N, or Aha1-C) was kept at half the Hsp90 con-
centration. When present, the concentration of AMPPNP was kept constant at 2.5
with 5 mM MgSO4. All spectra were acquired in 20 mM deuterated Tris pH 7.5,
100 mM NaCl, 0.5 mM EDTA, 1.5 mM DTT, and in 100% D2O. The assignment
performed by Dyson and coworkers was used41.
Isothermal titration calorimetry. For the data displayed in Supplementary
Table 3, titrations were carried out on a PEAQ-ITC calorimeter (Malvern Scientiﬁc,
Malvern, UK) at 36 °C, in 20 mM Tris pH 7.5, 100 mM NaCl, 0.5 mM EDTA, 5
mM MgSO4, and 1 mM Tris(2-carboxyethyl)phosphine. When indicated,
AMPPNP was included in both the cell and the syringe at a concentration of 2 mM.
The 200 μL sample cell was ﬁlled with Hsp90 at a concentration of 30 μM, and the
40 μL injection syringe was ﬁlled with Aha1 constructs at a concentration of
380–450 μM. All experiments were performed with an initial 0.2 μL injection fol-
lowed by twelve 3 μL injections, with a 4 min time interval between each injection.
Isotherms were processed using Origin 7.0, excluding the initial injection. All
titrations were performed in three technical repeats. The data presented in Sup-
plementary Table 2 were obtained separately and the ITC buffer contained 20 mM
Tris pH 7.5, 5 mM NaCl, 1 mM EDTA, and the temperature was 30 °C.
Analytical size exclusion chromatography (SEC). Frozen aliquots of wild-type
Hsp90 and Hsp90-Y313E in 20 mM Tris pH 7.5, 500 mM NaCl, 2 mM EDTA and
5mM 2-mercaptoethanol, at a concentration of ~5 mg/mL, were thawed and
exchanged in SEC-buffer (20 mM Tris pH 7.5, 100 mM NaCl, 0.5 mM EDTA, 1.5
mM DTT). Subsequently, proteins were concentrated to ~25 μM, and a 150 μL
sample was injected into an ENrichSEC650 10 × 300 column (Bio-Rad, Hercules,
CA) pre-equilibrated with SEC-buffer. Runs were performed at 4 °C, at a ﬂow rate
of 0.75 mL/min.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The cross-linking mass spectrometry data have been deposited to the ProteomeXchange
Consortium via the PRIDE partner repository with the dataset identiﬁer PXD013476.
The source data underlying Figs. 1, 2b–e, 3, 7, 8, Supplementary Figs. 2a, 3a, 3b, 3c, 6b,
and Supplementary Tables 2, and 3 are provided as a Source Data ﬁle. A reporting
summary for this Article is available as a Supplementary Information ﬁle. The mean
values used to calculate the HDX-MS data in Fig. 3 are provided in the Source Data ﬁle;
the data underlying these means and the raw mass spectrometric data are no longer
available. All other data supporting the ﬁndings of this study are available from the
corresponding author upon reasonable request.
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